• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Events

18th International Congress on Infectious Diseases

1-4 March 2018

Buenos Aires, Argentina

In collaboration with the XVIII Congreso de la Sociedad Argentina de Infectología (SADI, the Infectious Diseases Society of Argentina), the event’s objective is to cover all of the fields of infectious diseases with particular attention to the major challenges of the region, with both regional and international expertise. DNDi is a co-operating organization of the event.

Opening Ceremony

Date: Thursday, 1 March 2018
Time: 18:30 – 20:00

Long-Term Zika Complications
Vanessa Van der Linden Mota, Association for Assistance of Disabled Children, Brazil
Advances and Challenges in the Treatment of Chagas Disease – a Global Perspective
Sergio Sosa-Estani, Head of Chagas, DNDi Latin America, Argentina
Enteric Infections in Under Resourced Countries – From Research to Clinical Practice
Gagandeep Kang, Executive Director, Translational Health Science & Technology, India
The Human Microbiome
David Relman, Thomas C. and Joan M. Merigan Professor in Medicine, Microbiology & Immunology, Stanford University, USA
Emerging Infectious Diseases – The Next Pandemic
George Fu Gao, Professor and Director in CAS Key Laboratory of Pathogenic Microbiology and Immunology, Chinese Academy of Sciences, China

Parallel Symposium

New Outbreaks of Cutaneous Leishmaniasis and Management
In collaboration with DNDi

Date: Friday, 2 March 2018
Time: 17:00 – 18:00
Venue: Libertador A

Cutaneous Leishmaniasis Outbreaks and Management
Oscar Salomón, Director, National Institute of Tropical Medicine, Argentina
Cutaneous Leishmaniasis: Treatment Needs and Combination Therapies
Byron Arana, Head of Cutaneous Leishmaniasis, DNDi, Switzerland

Parallel Symposium

Alternative Strategies to Deliver Affordable Treatment for Hepatitis C Patients
In collaboration with DNDi

Date: Saturday, 3 March 2018
Time: 15:15 – 16:45
Venue:  Libertador B

HCV – Global Challenges
Marcelo Silva, Head of Hepatology and Liver Transplant Unit, Austral University Hospital, Argentina
Affordable Treatment Approaches for HCV with Sofosbuvir plus Ravidasvir Combination
Graciela Diap, Paediatric HIV/HCV, DNDi, Switzerland
Addressing IP Barriers To The Elimination of HCV As A Public Health Problem in Latin America
Francisco Viegas Neves da Silva, Regional Policy Advocacy Consultant, DNDi Latin America, Brazil

More information:

  • Event website
  • Scientific Programme
Clinical trials Chagas disease Cutaneous leishmaniasis Hepatitis C Argentina Latin America

Other events

Loading...
20 May 2025

Geneva, Switzerland

Strengthening the global ecosystem for paediatric medicines: leadership, collaboration, and impact

21 May 2025

Geneva, Switzerland

Scaling impact: Climate & health solutions that drive change

7-10 May 2025

Amsterdam, The Netherlands

EASL Congress 2025

20-25 May 2025

Iguaçu Falls, Brazil

22nd ISHAM Congress

See all

Stay connected

Get our latest news, personal stories, research articles, and job opportunities. 

Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License